Safety, pharmacodynamic response, and treatment satisfaction with onabotulinumtoxinA 40 U, 60 U, and 80 U in subjects with moderate-to-severe dynamic glabellar lines. (January 2021) - Cox, Sue Ellen; Joseph, John H.; Fagien, Steven; Glaser, Dee Anna; Bruce, Suzanne; Lain, Edward; Yoelin, Steven; Palm, Melanie; Maas, Corey S.; Lei, Xiaofang; Maltman, John; Sangha, Sara; et al.